What is the proper technique and dosing for administering amikacin injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Administer Amikacin Injection

Administer amikacin 15 mg/kg/day intramuscularly or intravenously as a single daily dose (or divided into 2-3 equal doses), with the IV route requiring dilution in 100-200 mL of compatible solution and infusion over 30-60 minutes in adults. 1

Route of Administration

Amikacin can be given via two routes:

  • Intramuscular (IM): Direct injection of the aqueous solution
  • Intravenous (IV): Preferred for most hospitalized patients, particularly those with severe infections

The IV route is more commonly used in clinical practice and allows for better control of drug delivery 2, 3, 2.

Standard Dosing

Adults with Normal Renal Function

  • Standard dose: 15 mg/kg/day (maximum 1.5 g/day) 2, 3, 2
  • Dosing frequency options:
    • 7.5 mg/kg every 12 hours, OR
    • 5 mg/kg every 8 hours 1
    • Once-daily dosing (15 mg/kg) is increasingly preferred based on pharmacodynamic principles 4, 5

Critical age adjustment: For patients >59 years, reduce dose to 10 mg/kg/day (750 mg maximum) 2, 3, 2

Pediatric Dosing

  • Children and adolescents: 15-30 mg/kg/day (maximum 1 g/day) as a single daily dose 2, 3, 2
  • Newborns: Loading dose of 10 mg/kg, followed by 7.5 mg/kg every 12 hours 1
  • Infants: Require 1-2 hour infusion time (longer than adults) 1

IV Administration Technique

Preparation

  1. Add contents of 500 mg vial to 100-200 mL of sterile diluent 1
  2. Compatible diluents include:
    • 0.9% sodium chloride injection
    • 5% dextrose injection
    • Lactated Ringer's injection
    • Various other solutions listed in drug labeling 1

Infusion Parameters

  • Adults: Infuse over 30-60 minutes 1
  • Pediatric patients: Infuse over 30-60 minutes (sufficient volume based on ordered dose) 1
  • Infants: Infuse over 1-2 hours 1

Critical safety point: Never physically premix amikacin with other drugs; administer separately 1

Dosing in Renal Impairment

Because amikacin is cleared almost exclusively by the kidneys, dosing adjustments are essential in renal insufficiency to prevent toxicity 2, 3, 2.

Two Adjustment Methods

Method 1: Normal dose at prolonged intervals

  • Calculate dosing interval (hours) = serum creatinine (mg/dL) × 9
  • Example: If creatinine = 2 mg/dL, give 7.5 mg/kg every 18 hours 1

Method 2: Reduced dose at fixed intervals

  • Give loading dose of 7.5 mg/kg initially
  • Maintenance dose every 12 hours = (observed CrCl/normal CrCl) × loading dose 1
  • Alternate method: Divide normal dose by serum creatinine value 1

For hemodialysis patients: Reduce frequency to 2-3 times weekly at 12-15 mg/kg per dose, and administer after dialysis to avoid premature drug removal 2, 3, 2

Therapeutic Drug Monitoring (TDM)

Mandatory monitoring is essential to ensure efficacy while avoiding toxicity 2, 3, 2, 6.

Target Concentrations

  • Peak levels (30-90 minutes after infusion):
    • Daily dosing: 25-35 mg/L 6
    • Three times weekly: 65-80 mg/L 6
    • Avoid levels >35 mcg/mL 1
  • Trough levels (just before next dose): <5-10 mg/L 6, 1

Monitoring Schedule

  • Peak serum level: First week, repeat if poor response 6
  • Trough levels: Weekly for 4 weeks, then can reduce to fortnightly when stable 6
  • Serum concentrations should be monitored whenever possible to guide dosing 1

Baseline and Ongoing Safety Monitoring

Before Starting Treatment

  • Audiogram
  • Vestibular testing
  • Romberg testing
  • Serum creatinine measurement 2, 3, 2, 3

During Treatment

  • Monthly assessments:
    • Renal function (serum creatinine)
    • Question regarding auditory or vestibular symptoms 2, 3, 2
  • Repeat audiogram and vestibular testing if symptoms of eighth nerve toxicity develop 2, 3, 2

Critical Safety Considerations

Major Toxicities

Nephrotoxicity (8.7% incidence):

  • More common with higher cumulative doses, pre-existing renal impairment, and concurrent nephrotoxic agents 2, 3, 2, 3
  • Risk factors include elevated baseline creatinine and concomitant vancomycin use 7

Ototoxicity:

  • Primarily causes deafness (less vestibular dysfunction than streptomycin) 2, 3, 2, 3
  • High-frequency hearing loss reported in 1.5-24% of patients 2, 3, 2
  • Risk increases with longer treatment, higher doses, and concurrent diuretics 2, 3, 2

Absolute Contraindications

Pregnancy: Amikacin is contraindicated due to risk of fetal nephrotoxicity and congenital hearing loss 2, 3, 2, 3, 2

Special Populations

Obesity

For markedly obese patients, use adjusted body weight for dosing:

  • Adjusted dose = ideal body weight + 40% of excess weight 6
  • Male ideal body weight (kg) = 50 + (2.3 × height in cm above 152.4)/2.54
  • Female ideal body weight (kg) = 45.5 + (2.3 × height in cm above 152.4)/2.54 6

Critically Ill Patients

Once-daily dosing of 15 mg/kg has shown superior clinical cure rates (83% vs 66%) and bacteriological cure rates (81% vs 58%) compared to twice-daily dosing in critically ill patients 4. However, doses ≥30 mg/kg may be required to achieve optimal peak concentrations in septic shock patients 8.

Duration of Treatment

  • Typical duration: 7-10 days 1
  • Limit treatment to short-term whenever feasible 1
  • If treatment >10 days is needed: Re-evaluate necessity and monitor amikacin serum levels, renal function, and auditory/vestibular function closely 1
  • For tuberculosis: Initially daily (5-7 days/week), then reduce to 2-3 times weekly after first 2-4 months or after culture conversion 2, 3, 2

Common Pitfalls to Avoid

  1. Failure to adjust for renal function: This is the most common cause of toxicity—always calculate creatinine clearance before dosing 2, 3, 2
  2. Inadequate TDM: Not monitoring levels can lead to both treatment failure and toxicity 1, 7
  3. Mixing with other drugs: Physical incompatibility can occur—always administer separately 1
  4. Using fixed dosing: Weight-based dosing is essential; fixed doses are not recommended 1
  5. Ignoring age: Patients >59 years require dose reduction even with normal renal function 2, 3, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.